UNSPSC 51283209: Tilmicosin

This classification denotes a macrolide antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XL4103X2E3. European Medicines Agency schedules Tilmicosin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11054MIG. Tilmicosin generally arises in the molecular formula C46H80N2O13. The term TILMICOSIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, no. 4, 1987, list 27.) Most nations schedule tilmicosin under HS 29419000 and SITC 54139.

As of Q4 2014, TILMICOSIN remains the US FDA Preferred Term for this commodity. Tilmicosin bears US NLM identifiers UMLS ID C0076681 and NCI Concept Code C84213. SMILES: O(C1C(CCN2CC(CC(C2)C)C)CC(C)C(=O)C=CC(=CC(C(OC(=O)CC(O)C1C)CC)COC1OC(C(O)C(OC)C1OC)C)C)C1OC(C(O)C(N(C)C)C1O)C.

UNSPSC 51283209 Tilmicosin is a Commodity code for a specific pharmaceutical active ingredient; however, the recent state and local opportunities tagged under this code show little activity directly aligned with tilmicosin procurement. The two posted opportunities name different pharmaceutical products entirely — one covers doxycycline hyclate and ciprofloxacin hydrochloride tablets through an Illinois Department of Public Health piggyback contract, and the other addresses naloxone and drug deactivation systems for Seminole County, Florida. State and local health departments and county public health authorities are the issuing bodies present in the tagged records, but the mismatch between the code's nominal scope (tilmicosin, a veterinary antibiotic) and the actual products being bought (human-use antibiotics and opioid-reversal agents) suggests either tagging inconsistency or limited recent tilmicosin-specific procurement activity in the state and local space.

Activity appears concentrated in Florida and Illinois based on the recent records. The Illinois Department of Public Health awarded a three-year pharmaceutical warehouse supply contract to Chartwell Rx LLC valued at $2,999,999.11 through the MMCAP Infuse cooperative purchasing consortium on August 28, 2026, with deliveries spanning the state. Seminole County, Florida posted an IFB on June 30, 2026 for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the county community health building. Neither opportunity reflects active tilmicosin demand. Vendors pursuing state and local pharmaceutical supply work should verify code alignment before bid submission, as this category shows limited recent tilmicosin-specific solicitation activity in the visible state and local pipeline.